Anti-VEGF therapy has resulted to be one of the most effective therapies for AMD (Age-Related Macular Degeneration) treatment, one of the leading causes of blindness in Europe. VEGF is a molecule that promotes the growth of the vessels and this, when turns out of control, causes severe problems as it is the case in the retina.
The 3rd International Scientific Meeting on VEGF as a clinically relevant molecule, symposium named as “VEGF and Beyond”, has gathered all well-known European experts in the field. The congress took place this last Saturday 08th of November of 2014 at the emblematic Charité Universitätsmedizin Berlin Hörsaal Ruin (Lecture Hall Ruin). The day was scheduled in both talks and scientific interaction by a poster session, where the ESR Sergio Crespo held a poster presenting part of his project within REVAMMAD (see below).
The experience resulted satisfactory as it was a great update in the cutting-edge of the field as it was for creating a high research network for prospective collaborations.